Drug maker Rohto plans clinical trials in Hong Kong as OASES’ first Japan partner
Advertisement
Firm’s chairman Kunio Yamada says city’s university research strength and proximity to mainland China are key draws
3-MIN READ3-MIN
Top university research, cross-border data exchanges and access to mainland China’s large market have attracted Japanese firm Rohto Pharmaceutical to conduct clinical trials in